Despite this activation, the presence of inhibitory molecules including PD‐1 and CTLA4 on the surface of T‐cells, overexpression of their respective ligands by tumor cells, and interaction with DAMP‐activated dendritic cells all work in tandem to suppress T‐cell function [29, 32]. This evidence concerns the gene CTLA4 and neoplasm.